Research Papers:
Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma
Metrics: PDF 1471 views | HTML 3115 views | ?
Abstract
Hanbin Chen1,*, Yangyang Li2,*, Yin Long3, Erjiang Tang3, Rongrong Wang2, Kate Huang2,*, Congying Xie1,* and Guorong Chen2,*
1Department of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
2Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
3Center for Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Yangpu, Shanghai, China
*These authors have contributed equally to this work
Correspondence to:
Kate Huang, email: [email protected]
Congying Xie, email: [email protected]
Guorong Chen, email: [email protected]
Key words: p16 protein, p53 protein, mucosal melanoma, prognosis of mucosal melanoma
Received: April 07, 2017 Accepted: May 10, 2017 Published: June 05, 2017
ABSTRACT
Primary mucosal melanoma (MM) is a rare, and aggressive, neoplasm with a poor prognosis. To date, few prognostic markers of MM have been well-defined. The aim of this study is to clarify the prognostic value of p53 and p16 proteins in predicting the clinical outcome of Chinese patients with MM.
A total of 59 MM samples were contained from biopsy specimens, and, expressions of p53 and p16 proteins were assessed by immunohistochemistry. Cox regression analysis was performed to investigate the association of these proteins with the overall survival of MM patients. Increased p16 expression was significantly associated with reduced survival at three years (P=0.039). Increased p53 expression correlates with reduced one-year (P=0.025), and, two-year survival (P=0.037).
Increased p53 and p16 protein expression may be helpful prognostic indicators for the management of these patients.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18367